Skip to main content

BARCLAYS PLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$80,654
-$351,022 QoQ
Shares Held
21,508
-85.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Derivatives in ACRS

reported options exposure · as of Mar 31, 2023
CallValue
$809,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. ACRS ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $80,654 21,508
2025-12-31 $431,676 143,414
2025-09-30 $234,507 123,425
2025-06-30 $221,998 156,337
2025-03-31 $182,071 119,001
2024-12-31 $37,698 15,201
2024-09-30 $23,451 20,393
2024-06-30 $44,269 40,245
2024-03-31 $84,649 68,266
2023-12-31 $184,714 175,919
2023-09-30 $1,603,926 234,150
2023-06-30 $885,483 85,389
2023-03-31 $809,000 100,000
2023-03-31 $717,500 88,690
2022-12-31 $674,257 42,810
2022-09-30 $262,967 16,707
2022-06-30 $306,686 21,969
2022-03-31 $1,038,813 60,256
2021-12-31 $1,461,531 100,518
2021-09-30 $903,042 50,169
2021-06-30 $206,627 11,767
2021-03-31 $453 18
2020-12-31 $116 18
2020-09-30 $46 18
2020-06-30 $13,436 8,294
2020-03-31 $10,936 10,516